Simvastatin Improves Mortality of Heart Failure Patients

MAY 01, 2005
Susan Farley

A recent study showed that 40 mg per day of simvastatin significantly improved mortality in heart failure patients over a 1-year follow-up period, compared with not taking the drug at all. Patients taking the statin also were less likely to develop blockage of their arteries. Moreover, simvastatin users were less likely to require a second angioplasty and experienced a survival rate of 80%, compared with 57% among patients not taking the drug. According to Myung Ho Jeong, MD, of Chonnam National University Hospital in Korea, this study indicates that "patients suffering from heart attacks and consequent heart pump failure can be improved after routine statin therapy." He further concluded that simvastatin can be a good treatment in addition to aspirin to effectively aid heart failure patients who have undergone angioplasty for a heart attack.

Ms. Farley is a freelance medical writer based in Wakefield, RI.



SHARE THIS SHARE THIS
0
 

The Oncology Care Pharmacist in Health-System Pharmacy 
According to the National Cancer Institute, almost 40% of men and women will be given a diagnosis of some form of cancer in their lifetime.


 

 

Conference Coverage
News from the year's biggest meetings


Pharmacist Education
Clinical features with downloadable PDFs


 

SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.